Debt-to-equity of ADIAL PHARMACEUTICALS, INC. from 30 Sep 2021 to 31 Dec 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
ADIAL PHARMACEUTICALS, INC. quarterly Debt-to-equity in % history and change rate from 30 Sep 2021 to 31 Dec 2025.
  • ADIAL PHARMACEUTICALS, INC. Debt-to-equity for the quarter ending 31 Dec 2025 was 29%.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

ADIAL PHARMACEUTICALS, INC. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q4 2025 29% 31 Dec 2025
Q3 2025 29% 30 Sep 2025
Q2 2025 25% 30 Jun 2025
Q1 2025 23% 31 Mar 2025
Q4 2023 37% -3.5% -8.8% 31 Dec 2023
Q3 2023 57% +12% +26% 30 Sep 2023
Q2 2023 57% +12% +25% 30 Jun 2023
Q1 2023 56% +4.2% +8.1% 31 Mar 2023
Q4 2022 40% -23% -37% 31 Dec 2022
Q3 2022 45% -5.4% -11% 30 Sep 2022
Q2 2022 46% 30 Jun 2022
Q1 2022 52% 31 Mar 2022
Q4 2021 64% 31 Dec 2021
Q3 2021 51% 30 Sep 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.